Efficiency of antiviral therapy for chronic hepatitis c in patients with undifferentiated connective tissue dysplasia
- 作者: Orlova S.N1, Baskhanova M.V1,2
-
隶属关系:
- Ivanovo State Medical Academy, Ministry of Health of Russia
- Republican Clinical Center of Communicable Diseases
- 期: 卷 9, 编号 2 (2019)
- 页面: 61-67
- 栏目: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287327
- DOI: https://doi.org/10.18565/epidem.2019.9.2.61-7
- ID: 287327
如何引用文章
详细
Objective. To determine the impact of undifferentiated connective tissue dysplasia (UCTD) on the efficiency of antiviral therapy (AVT) in patients with chronic hepatitis C (CHC). Subjects and methods. The investigation enrolled 71 patients receiving AVT for CHC, who were divided into 2 groups: 1) 48patients with signs of UCTD; 2) 23 patients without UCTD. Results. During dual AVT, a sustained virological response (SVR) was achieved in 75 and 91.3% in Groups 1 and 2, respectively. Patients with genotype 1 were recorded to have SVR in 64% cases in Group 1 and in 84.6% in Group 2. In patients with HCV genotypes 2 and 3, the achievement of SVR was even higher: in 86.9 and 100% of cases in Groups 1 and 2, respectively. Conclusion. The efficiency of AVT for CHC is associated with the presence of dysplastic manifestations in the patient. Dual AVT leads to SVR in 87% of the patients with chronic hepatitis C caused by HCV genotypes 2 and 3 and by UCTD and in 64% of those who have HCV genotype 1. There is 100% SVR in non- UCTD patients with HCV caused by HCV genotypes 2 and 85% SVR in those with HCV genotype 1. The presence of UCTD substantially affects the frequency and severity of adverse events occurring during AVT.
全文:
![受限制的访问](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
作者简介
S. Orlova
Ivanovo State Medical Academy, Ministry of Health of Russia
Email: orloff3.dok@mail.ru
Postgraduate Student, Department of Infectious Diseases, Epidemiology and Dermatovenereology Ivanovo, Russia
M. Baskhanova
Ivanovo State Medical Academy, Ministry of Health of Russia; Republican Clinical Center of Communicable Diseases
Email: marh.74@mail.ru
Postgraduate Student, Department of Infectious Diseases, Epidemiology and Dermatovenereology Ivanovo, Russia; Groznyi, Russia
参考
- Мухин H.A., Абдурахманов Д.Т., Розина Т.П., Лопаткина Т.Н., Никулкина Е.Н., Старостина Е.Е., Сидорова Е.И. Новые возможности противовирусной терапии хронического гепатита С у больных с неблагоприятными прогностическими факторами. Клиническая гепатология 2013; 1: 28-36.
- Знойко О.О., Дудина К.Р., Козина А.Н., Ленкова Д.О., Калинина О.В., Ющук Н. Д. Подводные камни при лечении больных хроническим гепатитом С, инфицированных генотипами 2 и 3 вируса гепатита С. Инфекционные болезни. Новости. Лечение. Обучение 2016; (1): 108-13.
- Сапронов Г.В., Николаева Л.И. Новые перспективы персонифицированной терапии хронического вирусного гепатита С Эпидемиология и инфекционные болезни 2013; (3): 27-36.
- Озолиня А.Ж. Биохимические аспекты реактивности соединительной ткани. Рига: Зинатне, 1986. 83 с.
- Чемоданов В.В., Краснова Е.Е. Принципы диагностики и тактика сопровождения детей с соединительнотканными дисплазиями. Вестник Ивановской медицинской академии 2015; 20(4): 5-14.
- Маколкин В.И., Подзолков В.И., Родионов А.В., Шеяно в М.В., Подзолков В.И., Родионов А.В., Шеянов М., Самойленко В.В., Напалков Д.А. Полиморфизм клинических проявлений синдрома соединительнотканной дисплазии. Тер. архив 2004; (11): 80-3.
- Martinez S.M., Crespo G., Navasa M., Forns X. Noninvasive assessment of liver fibrosis. Hepatology 2011; 53(1): 325-35.
- Loeys B.L., Dietz H.C., Braverman A.C. The revised Ghent nosology for the Marfan symdrome. J. Med. Genet. 2010; 47(7): 476-85.
- Ивашкин В.Т., Ющук Н.Д., Маевская М.В. Рекомендации по диагностике и лечению взрослых больных гепатитом С. Рос. журн. гастроэнтерологии, гепатологии и колопроктологии 2013; (2): 41-70.
- EASL. Recommendations on Treatment of Hepatitis 2014. htpp://files.easl.eu/easl-recommendations-on-trearment-of-hepatitis-C.pdf.
- EASL. Recommendations on Treatment of Hepatitis C 2015. J. Gastroenterology 2015; 63(1): 199-236.
- Desmet V.J., Gerber M., Hoofnagle J.H., Manns M., Scheuer P.J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
- Яковлев В.М., Глотов А.В., Ягода А.В. Иммунопатологические синдромы при наследственной дисплазии соединительной ткани. Ставрополь, 2005. 234 с.
补充文件
![](/img/style/loading.gif)